Magdalena Depa-Martynow: Silence Is Far More Dangerous Than Failure in IVF
Magdalena Depa-Martynow, Director, Global Clinical Science and Education at Nexpring Health, shared a post on LinkedIn:
“Is failure always bad in IVF?
In IVF, we work in a field where precision is everything.
We follow protocols step by step.
We control every variable we can.
Because a single mistake can be costly.
But not all failures are the same — and not all are harmful. There are three types of ‘failure’ in IVF:
1. Harmful failure
Errors that damage embryos, compromise safety, or break protocol.
These must be minimized — and openly discussed.
2. Learning failure
Small deviations, unexpected outcomes, or experiments that don’t work.
These are gold. They teach. They refine. They innovate.
3. Innovative failure
Trying something new because the old way isn’t good enough.
This is how ICSI was born.
This is how vitrification replaced slow freezing.This is how blastocyst culture became standard.
If the field punished every failure, we would still be doing IVF exactly like in 1978.
And here’s the truth we don’t say often enough:
Embryologists often see problems first.
Junior staff notice inconsistencies seniors overlook.
Nurses hear patient feedback clinicians never hear.
Lab techs spot micro‑failures before they become macro‑failures.
But none of that matters if people don’t feel safe to speak.
Leadership sets the tone.
Leaders decide whether people:
- admit mistakes
- ask questions
- challenge dogmas
- propose new ideas
Without psychological safety, teams stay silent.
And silence is far more dangerous than failure.
So, a better question for our field is this:
Is the way we approach failure always good?
What do You think?”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 11, 2026, 12:18Celebrating Innovation and Impact at the RCOG, WHH London Summit 2026! – WHH
-
Jun 11, 2026, 12:11Barb Collura: Join Women’s Health Advocates on June 18
-
Jun 11, 2026, 12:07Gabriel Levin: Surgical Approach and Survival in Stage I Uterine Leiomyosarcoma
-
Jun 11, 2026, 11:59PCOS Is Not the Fire, It Is the Smoke Alarm – Fertility Plus
-
Jun 11, 2026, 11:57Christopher Robinson: The Nausicaä Suture in the Management of Placenta Accreta Spectrum
-
Jun 11, 2026, 11:54Kirti Gupta: Next-Generation Women’s Health Through Innovation and Precision Care
-
Jun 11, 2026, 11:52Asma Khalil: AI-Assisted Ultrasound Is Changing Point-of-Care Imaging
-
Jun 11, 2026, 11:51Marco Zaccaria: ENDOCWB 2026 Bringing Innovation, Expertise and Excellence in Gynecological Surgery
-
Jun 11, 2026, 11:47AMPLI-PPHI: Catalysing Learning and Shaping the Global Trajectory of PPH – IJGO
